phenserine has been researched along with alpha-synuclein in 2 studies
Studies (phenserine) | Trials (phenserine) | Recent Studies (post-2010) (phenserine) | Studies (alpha-synuclein) | Trials (alpha-synuclein) | Recent Studies (post-2010) (alpha-synuclein) |
---|---|---|---|---|---|
88 | 6 | 39 | 10,821 | 29 | 8,011 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Greig, NH; Holloway, HW; Kamal, MA; Lahiri, DK; Luo, W; Ray, B; Reale, M; Rogers, JT; Sambamurti, K; Yu, QS | 1 |
Balleidier, A; Bandyopadhyay, S; Cahill, C; Huang, C; Huang, X; Lahiri, DK; Rogers, JT | 1 |
2 other study(ies) available for phenserine and alpha-synuclein
Article | Year |
---|---|
Synthesis of the Alzheimer drug Posiphen into its primary metabolic products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their inhibition of amyloid precursor protein, α-Synuclein synthesis, interleukin-1β release, and cholinergi
Topics: alpha-Synuclein; Alzheimer Disease; Amyloid beta-Protein Precursor; Humans; Interleukin-1beta; Physostigmine; Plaque, Amyloid; Receptors, Muscarinic; Receptors, Nicotinic; Stereoisomerism | 2013 |
Novel 5' untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer's disease.
Topics: 5' Untranslated Regions; alpha-Synuclein; Alzheimer Disease; Amyloid beta-Protein Precursor; Aniline Compounds; Animals; Base Sequence; Benzimidazoles; Blotting, Western; Cell Line, Tumor; Cell Survival; Cells, Cultured; Down Syndrome; Humans; Iron; Iron Regulatory Protein 1; Mice; Mice, Transgenic; Molecular Sequence Data; Neurons; Physostigmine; Protein Binding; Protein Biosynthesis; Response Elements; RNA, Messenger; Sequence Homology, Nucleic Acid | 2013 |